Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia

Journal of Cellular Biochemistry

Volumn 76, Issue SUPPL. 32/33, 1999, Pages 51-58

  Westendorf, Jennifer J ^a   Hiebert, Scott W ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

AML1; AML2; AML3; Bone; CBFA; Cleidocranial dysplasia; ETO; Leukemia; Osteoblasts; PEPB2 ; Runx

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; RUNT DOMAIN PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ONCOPROTEIN; RUNX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHROMOSOME MAP; CLEIDOCRANIAL DYSPLASIA; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MAMMAL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

MAMMALIA;

ANIMALS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMANS; LEUKEMIA; NEOPLASM PROTEINS; OSTEOGENESIS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 0033256932     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4644(1999)75:32+<51::aid-jcb7>3.3.co;2-j     Document Type: Article

References (18)

1. Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP. 1997. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol Cell Biol 17:5581-5587.
2. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS. 1996. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93:4968-4973.
3. Bruhn L, Munnerlyn A, Grosschedl R. 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev 11:640-653.
4. Deguchi K, Yagi H, Inada M, Yoshizaki K, Kishimoto T, Komori T. 1999. Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow. Biochem Biophys Res Commun 255:352-359.
5. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments). Cell 89:747-754.
6. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036.
7. Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR, Hiebert SW. 1999. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 19:6566-6574.
8. Geoffroy V, Ducy P, Karsenty G. 1995. APEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270:30973-30979.
9. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M. 1998. CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 69:353-363.
10. Kanno T, Kanno Y, Chen LF, Ogawa E, Kim WY, Ito Y. 1998. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol 18:2444-2454.
11. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. 1998a. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 17:2994-3004.
12. Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M. 1998b. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol Cell Biol 18:846-858.
13. Kogan SC, Lagasse E, Atwater S, Bae SC, Weissman I, Ito Y, Bishop JM. 1998. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc Natl Acad Sci USA 95:11863-11868.
14. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comments]. Cell 89:755-764.
15. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y. 1998. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci USA 95:11590-11595.
16. Lutterbach B, Hiebert SW. 2000. The role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene (in press).
17. Lutterbach B, Sun D, Schuetz J, Hiebert SW. 1998a. The MYND motif is required for repression of basal transcrip-tion from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 18:3604-3611.
18. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. 1998b. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18:7176-7184.